Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04616560
What this trial is testing

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

Who this might be right for
Desmoplastic Small Round Cell TumorOsteosarcomaRecurrent Desmoplastic Small Round Cell Tumor+5 more
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Study completedNCT05708950
What this trial is testing

A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

Who this might be right for
CancerSolid TumorMelanoma+14 more
Kineta Inc. 40
Large-scale testing (Phase 3)Study completedNCT00919815
What this trial is testing

Ciclosporin in the Management of New Type 1 Reactions in Leprosy

Who this might be right for
Leprosy
London School of Hygiene and Tropical Medicine 73
Testing effectiveness (Phase 2)UnknownNCT01240525
What this trial is testing

Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
University College, London 114
Not applicableEnded earlyNCT00608517
What this trial is testing

Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Vanderbilt-Ingram Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT04764968
What this trial is testing

Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes

Who this might be right for
Type 1 DiabetesHypoglycemia
Steno Diabetes Center Copenhagen 24
Not applicableStudy completedNCT01302418
What this trial is testing

Collection and Testing of Respiratory Samples

Who this might be right for
QIAGEN ResPlex II Advanced PanelInfluenza ARespiratory Syncytial Virus Infections+15 more
QIAGEN Gaithersburg, Inc 272
Not applicableEnded earlyNCT04007003
What this trial is testing

An Audit of the Impact of Tailored Information Delivered Via a Digital Learning Platform

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Becton, Dickinson and Company 170
Early research (Phase 1)Study completedNCT00962026
What this trial is testing

Rilonacept in Diabetes Mellitus Type 1: Safety Study

Who this might be right for
Type 1 Diabetes Mellitus
University of Texas Southwestern Medical Center 13
Testing effectiveness (Phase 2)Study completedNCT00541008
What this trial is testing

Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer

Who this might be right for
Kidney Cancer
UNICANCER 92
Early research (Phase 1)Study completedNCT01634750
What this trial is testing

Phase I Clinical Trial of ManNAc in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)

Who this might be right for
Hereditary Inclusion Body Myopathy (HIBM)GNE Myopathy
National Human Genome Research Institute (NHGRI) 26
Not applicableNot Yet RecruitingNCT07750210
What this trial is testing

Study of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Adults With Type 1 Diabetes

Who this might be right for
MASLDType 1 Diabetes
Sohag University 250
Testing effectiveness (Phase 2)Study completedNCT02644759
What this trial is testing

Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus Type 1Autoimmune DiseasesEndocrine System Diseases+3 more
Stem Cells Arabia 100
Not applicableStudy completedNCT03258840
What this trial is testing

EPA Supplementation on Vascular Inflammation, and Gene Expression of PON2 in Patients With Type II Diabetes Mellitus

Who this might be right for
Diabetes Mellitus Type II
Tehran University of Medical Sciences 36
Early research (Phase 1)Ended earlyNCT03685591
What this trial is testing

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

Who this might be right for
Breast NeoplasmsProstate NeoplasmsNeoplasms, Squamous Cell+6 more
Pfizer 49
Early research (Phase 1)Ended earlyNCT04123418
What this trial is testing

WVT078 in Patients With Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma (MM)
Novartis Pharmaceuticals 56
Not applicableStudy completedNCT03414320
What this trial is testing

Proof of Concept - Identification of Patient-specific Parameters for Bolus Calculators for Type 1 Diabetes

Who this might be right for
Type1 Diabetes Mellitus
Universitaire Ziekenhuizen KU Leuven 21
Large-scale testing (Phase 3)Study completedNCT01467323
What this trial is testing

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 303
Large-scale testing (Phase 3)Active Not RecruitingNCT04695080
What this trial is testing

ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis

Who this might be right for
Advanced Multiple SclerosisProgressive Multiple Sclerosis
Queen Mary University of London 204
Early research (Phase 1)Looking for participantsNCT06799026
What this trial is testing

Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple MyelomaRelapse Multiple MyelomaRefractory Multiple Myeloma
David Avigan 25
Next Page